Full Text
A Holistic Approach to Evaluate the Cost-Effectiveness of Pembrolizumab with Multiple Indications- A Norway-Based Example

Abstract

Authors

E Wu J Pellissier M Kvamme K Irgens

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×